436151-97-2 Usage
Description
4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine is a chemical compound with the molecular formula C10H8F3N3OS. It is a thiazole derivative featuring a trifluoromethoxyphenyl group attached to the 4-position of the thiazole ring. 4-(3-TRIFLUOROMETHOXY-PHENYL)-THIAZOL-2-YLAMINE is known for its unique structure and potential therapeutic properties, which make it a promising candidate in medicinal chemistry and drug development. Thiazoles are recognized for their diverse biological activities, such as antimicrobial, antitumor, and anti-inflammatory effects, and the trifluoromethoxyphenyl group may augment these properties. Further research is essential to explore the full spectrum of applications and impacts of 4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine.
Uses
Used in Pharmaceutical Industry:
4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine is used as a potential active pharmaceutical ingredient for the development of new drugs due to its unique structure and potential therapeutic properties. Its biological activities, including antimicrobial, antitumor, and anti-inflammatory effects, make it a valuable compound for the treatment of various diseases and conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine serves as a key compound for studying its structure-activity relationships and exploring its potential as a lead molecule for drug discovery. 4-(3-TRIFLUOROMETHOXY-PHENYL)-THIAZOL-2-YLAMINE's unique features and biological activities provide a foundation for designing and optimizing new therapeutic agents with improved efficacy and selectivity.
Used in Drug Delivery Systems:
4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine may also be utilized in the development of drug delivery systems to enhance the bioavailability, targeting, and therapeutic outcomes of drugs. Its unique structure and properties can be leveraged to design novel carriers, such as nanoparticles or other nanoscale delivery platforms, to improve the delivery and efficacy of therapeutic agents.
Used in Antimicrobial Agents:
Given its antimicrobial properties, 4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine can be employed as an antimicrobial agent for the treatment of bacterial infections. Its unique structure and potential to target specific bacterial mechanisms make it a promising candidate for the development of new antibiotics to combat drug-resistant bacteria.
Used in Anti-inflammatory Therapies:
The anti-inflammatory properties of 4-(3-Trifluoromethoxy-phenyl)-thiazol-2-ylamine make it a potential candidate for the development of anti-inflammatory drugs. It can be used to treat various inflammatory conditions, such as arthritis, asthma, and other autoimmune diseases, by modulating the immune response and reducing inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 436151-97-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,6,1,5 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 436151-97:
(8*4)+(7*3)+(6*6)+(5*1)+(4*5)+(3*1)+(2*9)+(1*7)=142
142 % 10 = 2
So 436151-97-2 is a valid CAS Registry Number.
436151-97-2Relevant articles and documents
SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES
-
Page/Page column 14-15; 40; 45-46, (2019/11/12)
The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.
FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS
-
Page/Page column 41, (2010/11/03)
The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPAl (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPAl. Formula (I)
QUINAZOLINEDIONE DERIVATIVES AS TRPA1 MODULATORS
-
Page/Page column 17, (2010/01/31)
The present invention provides Quinazolinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by T
